Extract from the Register of European Patents

EP About this file: EP2802672

EP2802672 - CYCLON EXPRESSION FOR THE IDENTIFICATION AND CONTROL OF CANCER CELLS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.07.2018
Database last updated on 19.03.2026
FormerGrant of patent is intended
Status updated on  26.09.2017
FormerExamination is in progress
Status updated on  09.11.2016
Most recent event   Tooltip06.07.2018Application deemed to be withdrawnpublished on 08.08.2018  [2018/32]
Applicant(s)For all designated states
Université Joseph Fourier - Grenoble 1
621 Avenue Centrale
38400 Saint-Martin-d'Hères / FR
For all designated states
Centre Hospitalier Universitaire Grenoble
Hôpital Nord Boulevard de la Chantourne
38700 La Tronche / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
25, Rue Leblanc
Bâtiment "Le Ponant D"
75015 Paris / FR
[N/P]
Former [2014/47]For all designated states
Universite Joseph Fourier - Grenoble 1
621 Avenue Centrale
38400 St. Martin d'Heres / FR
For all designated states
Centre Hospitalier Universitaire Grenoble
Hôpital Nord Boulevard de la Chantourne
38700 La Tronche / FR
For all designated states
Centre National de la Recherche Scientifique (CNRS)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
25, rue Leblanc
Bâtiment "Le Ponant D"
75015 Paris / FR
Inventor(s)01 / CALLANAN, Mary
320 chemin du Meffrey
38410 Saint-Martin-d'Uriage / FR
02 / EMADALI, Anouk
3 rue Arago
F-38000 Grenoble / FR
03 / FERRO, Myriam
22 jardins de Marquetière
F-38120 Fontanil-Cornillon / FR
04 / KHOCHBIN, Saadi
5 allée de la Praly
F-38240 Meylan / FR
05 / PISON-ROUSSEAUX, Sophie
7 allée St Ferriol
F-38410 St Martin d'Uriage / FR
 [2014/47]
Representative(s)Regimbeau
87 rue de Sèze
69477 Lyon Cedex 06 / FR
[N/P]
Former [2014/47]Regimbeau
139, rue Vendôme
69477 Lyon Cedex 06 / FR
Application number, filing date13700154.110.01.2013
WO2013EP50336
Priority number, dateEP2012030503110.01.2012         Original published format: EP 12305031
[2014/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013104688
Date:18.07.2013
Language:EN
[2013/29]
Type: A1 Application with search report 
No.:EP2802672
Date:19.11.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.07.2013 takes the place of the publication of the European patent application.
[2014/47]
Search report(s)International search report - published on:EP18.07.2013
ClassificationIPC:C12Q1/68, A61K39/00
[2014/47]
CPC:
C12Q1/6886 (EP,US); G01N33/57595 (US); A61K31/713 (EP,US);
A61K39/39558 (EP,US); A61K45/06 (US); C07K16/2887 (EP,US);
C07K2317/73 (EP,US); C07K2317/734 (EP,US); C07K2317/75 (US);
C12Q2600/106 (EP,US); C12Q2600/118 (US); C12Q2600/136 (EP,US);
C12Q2600/158 (EP,US); G01N2333/4715 (US) (-)
C-Set:
A61K39/39558, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/47]
TitleGerman:CYCLONEXPRESSION ZUR IDENTIFIZIERUNG UND BEKÄMPFUNG VON KREBSZELLEN[2017/24]
English:CYCLON EXPRESSION FOR THE IDENTIFICATION AND CONTROL OF CANCER CELLS[2014/47]
French:EXPRESSION DE CYCLONE POUR L'IDENTIFICATION ET LE CONTRÔLE DES CELLULES CANCÉREUSES[2017/24]
Former [2014/47]ZYKLONEXPRESSION ZUR IDENTIFIKATION UND KONTROLLE VON KREBSZELLEN
Former [2014/47]EXPRESSION DU CYCLON POUR IDENTIFIER ET RÉGULER DES CELLULES CANCÉREUSES
Entry into regional phase06.08.2014National basic fee paid 
06.08.2014Designation fee(s) paid 
06.08.2014Examination fee paid 
Examination procedure06.08.2014Examination requested  [2014/47]
11.03.2015Amendment by applicant (claims and/or description)
18.12.2015Despatch of a communication from the examining division (Time limit: M06)
22.06.2016Reply to a communication from the examining division
31.10.2016Despatch of a communication from the examining division (Time limit: M04)
24.02.2017Reply to a communication from the examining division
27.09.2017Communication of intention to grant the patent
08.02.2018Application deemed to be withdrawn, date of legal effect  [2018/32]
19.03.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2018/32]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.12.2015
Request for further processing for:11.03.2015Request for further processing filed
11.03.2015Full payment received (date of receipt of payment)
Request granted
23.03.2015Decision despatched
Fees paidRenewal fee
09.01.2015Renewal fee patent year 03
28.01.2016Renewal fee patent year 04
20.12.2016Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.01.201806   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]   JUNG-HWA OH ET AL: "Transcriptome analysis of human gastric cancer", MAMMALIAN GENOME, SPRINGER-VERLAG, NE, vol. 16, no. 12, 1 December 2005 (2005-12-01), pages 942 - 954, XP019365794, ISSN: 1432-1777

DOI:   http://dx.doi.org/10.1007/s00335-005-0075-2
 [XY]   WANG A G ET AL: "Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 345, no. 3, 7 July 2006 (2006-07-07), pages 1022 - 1032, XP024925190, ISSN: 0006-291X, [retrieved on 20060707], DOI: 10.1016/J.BBRC.2006.04.175

DOI:   http://dx.doi.org/10.1016/j.bbrc.2006.04.175
 [XDA]   HOSHINO ET AL: "Redundant promoter elements mediate IL-3-induced expression of a novel cytokine-inducible gene, cyclon", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 581, no. 5, 24 February 2007 (2007-02-24), pages 975 - 980, XP005916857, ISSN: 0014-5793, DOI: 10.1016/J.FEBSLET.2007.01.083

DOI:   http://dx.doi.org/10.1016/j.febslet.2007.01.083
ExaminationUS2003219818
by applicant  BASSO, K.; A.A. MARGOLIN; G. STOLOVITZKY; U. KLEIN; R. DALLA-FAVERA; A. CALIFANO: "Reverse engineering of regulatory networks in human B cells", NAT GENET., vol. 37, 2005, pages 382 - 90
   BOMPAS E; VELAY B; BLAY JY., LEUK LYMPHOMA, vol. 45, no. 11, November 2004 (2004-11-01), pages 2353 - 4
   BRECCIA M; MARTELLI M; CANNELLA L; RUSSO E; FINOLEZZI E; STEFANIZZI C; LEVI A; FRUSTACI A; ALIMENA G., LEUK RES., vol. 32, no. 2, February 2008 (2008-02-01), pages 353 - 5
   CHESON, B.D.; J.P. LEONARD: "Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma", N ENGL J MED., vol. 359, 2008, pages 613 - 26
   HOSHINO, A.; H. FUJII: "Redundant promoter elements mediate IL-3- induced expression of a novel cytokine-inducible gene, cyclon", FEBS LETT., vol. 581, 2007, pages 975 - 80
   LENZ, G.; G. WRIGHT; S.S. DAVE; W. XIAO; J. POWELL; H. ZHAO; W. XU; B. TAN; N. GOLDSCHMIDT; J. IQBAL: "Stromal gene signatures in large-B-cell lymphomas", N ENGI J MED., vol. 359, 2008, pages 2313 - 23
   ORCIUOLO E; FAZZI R; GALIMBERTI S; TESTI C; AZZARA' A; CARULLI G; PETRINI M., LEUK RES., vol. 30, no. 3, pages 349 - 53
   ROBAK, T.; E. ROBAK: "New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies", BIODRUGS, vol. 25, 2011, pages 13 - 25
   SAINT FLEUR, S.; A. HOSHINO; K. KONDO; T. EGAWA; H. FUJII: "Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon", BLOOD, vol. 114, 2009, pages 1355 - 65
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.